Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
It functions as a powerful antioxidant, shielding the skin from cell damage
Its validated clinical profile distinguishes it from all other molecules in the class
Pfizer, after discontinuing its initial danuglipron candidate due to safety concerns in April 2025, re-entered the race through a $10 billion acquisition of clinical-stage biotech Metsera in November 2025, securing a next-generation obesity pipeline [43]
10% off subsequent labs
If pancreatitis is suspected, discontinue Ozempic or Rybelsus tablets and initiate appropriate management Diabetic Retinopathy Complications: In a pooled analysis of glycemic control trials, patients reported diabetic retinopathy related adverse reactions during the trial (4.2% with semaglutide tablets and 3.8% with comparator)
